{"version":"1.0","type":"link","title":"Fuzuloparib plus apatinib in BRCA-mutated breast cancer: balancing efficacy and accessibility in regional China.","author_name":"Qiu Z 외","author_url":"https://prs-insight.online/author/Qiu%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/82773","thumbnail_width":1200,"thumbnail_height":630}